Recombinant long-acting glycoPEGylated factor IX (nonacog beta pegol) in haemophilia B: assessment of target joints in multinational phase 3 clinical trials - Negrier, C; Young, G; Abdul Karim, F; paradigm™ 2 and 4 Investigators (Haemophilia, 2016)